Protective effect of captopril on ischemic myocardium

Japanese Circulation Journal

Volumn 61, Issue 2, 1997, Pages 161-169

  Yanagishita, Toshikuni ^a   Tomita, Masataka ^a   Itoh, Seiji ^a   Mukae, Shuji ^a   Arata, Hirohisa ^a   Ishioka, Haruhiko ^a   Geshi, Eiichi ^a   Konno, Noburu ^a   Katagiri, Takashi ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Canine heart; Captopril; Ischemic myocardial injury; Mitochondria; Sarcoplasmic reticulum; Sulfhydryl group

Indexed keywords

2,4 DINITROPHENOL; ADENOSINE TRIPHOSPHATASE (CALCIUM); CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIOL GROUP;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOG; DRUG MECHANISM; ELECTRON TRANSPORT; ENZYME ACTIVITY; HEART MITOCHONDRION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MITOCHONDRIAL RESPIRATION; NONHUMAN; SARCOPLASMIC RETICULUM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CALCIUM-TRANSPORTING ATPASES; CAPTOPRIL; DOGS; HEMODYNAMIC PROCESSES; MEMBRANE PROTEINS; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA; NAD(P)H DEHYDROGENASE (QUINONE); OXYGEN CONSUMPTION; SARCOPLASMIC RETICULUM; SULFHYDRYL COMPOUNDS;

EID: 0030889792     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.61.161     Document Type: Article

References (36)

1. Bakhle YS: Conversion of angiotensin I to angiotensin II by cell free extracts of dog lungs. Nature 1968; 220: 919-921
2. Carretero OA, Miyazaki S, Scicli AG: Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril. Hypertension 1981; 3: 18-22
3. Oliver JA, Sciacca RR: Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat. J Clin Invest 1984; 74: 1247-1251
4. Unger T, Gohike P, Ganten D, Lang RE: Converting enzyme inhibitors and their effects on the renin- angiotensin system of the blood vessel wall. J Cardiovasc Pharmacol 1989; 13(Suppl 3): 8-16
5. Kiowski W, Linder L, Kleinbloesem C, Brummelen P, Buhler FR: Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin-converting enzyme and renin inhibition. Circulation 1992; 85: 1-8
6. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302
7. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-691
8. The SAVE Investigators: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327: 669-677
9. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H: Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the cooperative new Scandinavian enalapril survival study II (CONSENSUS II). N Engl J Med 1992; 327: 678-684
10. Mattioli G, Ricci S, Rigo R, Fusaro MT, Cappello C: Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute hemodynamic effects in chronic heart failure after 3 years of treatment. Postgrad Med J 1986; 62(Suppl 1): 164-166
11. Gilst WH, Graeff PA, Wesseling H, Langen CDJ: Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin-converting enzyme inhibitors. A comparison of captopril, enalapril, and HOE 498. J Cardiovasc Pharmacol 1986; 8: 722-728
12. Westin W, Mullane K: Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation 1988; 77(Suppl 1): 30-39
13. Gilst WH, Scholtens E, Graeff PA, Langen CDJ, Wesseling H: Differential influences of angiotensin converting- enzyme inhibitors on the coronary circulation. Circulation 1988; 77(Suppl 1): 24-29
14. Konno N, Yanagishita T, Geshi E, Katagiri T: Degradation of the cardiac sarcoplasmic reticulum in acute myocardial ischemia. Jpn Circ J 1987; 51: 411-420
15. Geshi E, Konno N, Yanagishita T, Katagiri T: Impairment of mitochondrial respiratory activity in the early ischemic myocardium. Jpn Circ J 1988; 52: 535-542
16. 2+-ATPase. Arch Biochem Biophys 1986; 246: 589-601
17. Trimm JL, Salama G, Abramson JJ: Sulfhydryl oxidation induces rapid calcium release from sarcoplasmic vesicles. J Biol Chem 1986; 261: 16092-16098
18. Harigaya S, and Schwartz A: Role of calcium binding and uptake in normal and failing human cardiac muscle. Circ Res 1969; 25: 781-794
19. Sordahl LA, Stewart ML: Mechanism of altered mitochondrial calcium transport in acutely ischemic canine heart. Circ Res 1980; 47: 814-820
20. Fiske CH and Subbarow Y: The coloriometric determination of phosphorus. J Biol Chem 1925; 66: 375-400
21. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
22. Hagihara B: Techniques for application of polarography to mitochondrial respiration. Biochim Biophys Ada 1961; 46: 134-142
23. Chance B, Williams GR: Respiratory enzymes in oxidative phosphorylation. Kinetics of oxygen utilization. J Biol Chem 1955; 217: 383-393
24. Hatefi Y, Rieske JS: Preparation and properties of DPNH-coenzyme Q reductase (complex I of the respiratory chain). In: Estabrook RW and Pullman ME, Methods in Enzymology: Vol. X, Oxidation and phosphorylation. Academic Press, New York: 1967; 235-239
25. Pullman ME, Penefsky HS, Datta A, Racker E: Partial resolution of the enzymes catalyzing oxidative phosphorylation. I. Purification and properties of soluble dinitrophenol-stimulated adenosine triphosphate. J Biol Chem 1960; 235: 3322-3329
26. Ellmann GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77
27. Jugdutt BI: Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model. J Am Coll Cardiol 1995; 25: 1718-1725
28. Bussmann W-D, Micke G, Hildenbrand R, Klepzig H: Captopril-treated in acute myocardial infarction. Beneficial effects on infarct size and arrhythmias. Presse Med 1995; 24: 345-350
29. Jugdutt BI, Khan MI, Jugdutt SJ, Bliston GE: Combined captopril and isosorbide dinitrate during healing after myocardial infarction. J Am Coll Cardiol 1995; 25: 1089-11096
30. Yanagishita T, Konno N, Geshi E, Katagiri T: Alterations in phospholipids in acute ischemic myocardium. Jpn Circ J 1987; 51: 41-50
31. Tanno F, Akiyama K, Geshi E, Yanagishita T, Konno N, Katagiri T: Impairment of sarcolemmal permeability in the acute ischemic myocardium. A study with ionic lanthanum probe method. Jpn Circ J 1992; 56: 911-920
32. Katagiri T, Mochizuki M, Umetsu K, Hiroshige J, Geshi E, Konno N: Protection of acute ischemic myocardial injury by pharmacological intervention. Jpn Circ J 1989; 53: 1108-1114
33. Longobardi G, Ferrara N, Leosco D, Nicolino A, Acanfora D, Furgi G, et al: Failure of protective effect of captopril and enalapril on exercise and dipyridamole-induced myocardial ischemia. Am J Cardiol 1995; 76: 255-258
34. Yanagishita T, Matsuoka T, Kako KJ: Pharmacological intervention in oxidant-induced calcium pump dysfunction of dog heart. Biochem Int 1989; 18: 1111-1119
35. Jay D, Cuella A, Jay E: Superoxide dismutase activity of captopril-iron complex. Mol Cell Biochem 1995; 146: 45-47
36. Lesnefsky EJ, Dauber IM, Horwitz LD : Myocardial sulfhydryl pool alterations occur during reperfusion after brief and prolonged myocardial ischemia in vivo. Circ Res 1991; 68: 605-613